The Wuhan Cover-Up Book › Citations Chapter 51 This is a listing of all citations in this chapter. 31 Sharri Markson, “How US Cash Funded Wuhan Lab Dealing in Deadly Viruses,” The Times UK, Sep. 4, 2021. 32 Ibid. 33 American Consulate Wuhan, SBU Cable, “China Virus Institute Welcomes More U.S. Cooperation on Global Health Security,” US Right to Know, Apr. 19, 2019, 9. 34 Allison L. Totura et al., “Broad-spectrum Coronavirus Antiviral Drug Discovery,” Expert Opin. Drug Discovery 14, no. 4 (2019): 397-412, doi: 10.1080/17460441.2019.1581171. 35 “Professor George Fu Gao,” Hong Kong Institute for Advanced Study/Senior Fellows. 36 George F. Gao, “For a Better World: Biosafety Strategies to Protect Global Health,” Biosafety Health 1, no. 1 (2019): 1-3, doi: 10.1016/j.bsheal.2019.03.001. 37 Ibid. 38 Yuan Zhiming, “Current Status and Future Challenges of High-Level Biosafety Laboratories in China,” Journal of Biosafety and Biosecurity 1, no. 2 (2019): 123-127, doi: 10.1016/j.jobb.2019.09.005. 39 “Event 201,” Johns Hopkins Center for Health Security. 40 Ibid. 41 Emily Kopp, “U.S. Right to Know Confirms a Third Maximum Containment Lab in China,” US Right to Know, Apr. 26, 2022. 42 Liu Caiya, “New Law Fortifies China’s Legal Shield on Biosecurity Labs against Future Infectious Diseases,” Global Times, Apr. 15, 2021. 43 Rowan Jacobsen, “Inside the Risky Bat-Virus Engineering that Links America to Wuhan,” MIT Technology Review, Jun. 29, 2001. 44 Yuan Zhiming, “Current Status and Future Challenges of High-Level Biosafety Laboratories in China,” Journal of Biosafety and Biosecurity 1, no. 2 (2019): 123–127, doi: 10.1016/j.jobb.2019.09.005. 45 Sharon Lerner and Mara Hvistendahl, “New Details Emerge about Coronavirus Research at Chinese Lab,” The Intercept, Sep. 6, 2021. 46 Arthur Trapotsis, “Biosafety Levels 1, 2, 3 & 4: What’s the Difference?” Consolidated Sterilizer Systems, Nov. 3, 2022. 47 Peter Daszak, “RE: Grant Number: 5R01Al110964—03 Pl Name: DASZAK, PETER,” email message to Erik Stemmy, Jenny Greer, and Alexsei Chmura (Obtained under the Freedom of Information Act by White Coat Waste Project), 155. 48 Sainath Suryanarayanan, “Emails Cast Doubt on Safety Protocols at Wuhan Lab Where U.S. Researchers Conducted Coronavirus Experiments,” The Defender, Jan. 4, 2022. 49 Dorren H. Bartlett to Alexsei Chmura, May 19, 2014 (Obtained under the Freedom of Information Act by White Coat Waste Project), 229-232. 50 Bad Faith, “Lab Leak Theory: New Evidence? (w/ Jeffery [sic] Sachs),” YouTube, 00:18:21-00:18:59, May 30, 2022. 51 James LeDuc to David Franz, Jun. 2, 2021 (Obtained through a Texas Public Information Act request to the University of Texas Medical Branch by US Right to Know). 52 Sainath Suryanarayanan, “Emails Cast Doubt on Safety Protocols at Wuhan Lab Where U.S. Researchers Conducted Coronavirus Experiments,” The Defender, Jan. 4, 2022. 53 Ibid. 54 David Franz to James LeDuc, “Re: Arms controllers informal discussion,” Jun. 2, 2021 (Obtained through a Texas Public Information Act request to the University of Texas Medical Branch by US Right to Know). 55 James LeDuc to David Franz, “Re: SCIENCE [letter] Investigate the origins of COVID-19,” May 15, 2021 (Obtained through a Texas Public Information Act request to the University of Texas Medical Branch by US Right to Know). 56 Sainath Suryanarayanan, “Emails Cast Doubt on Safety Protocols at Wuhan Lab Where U.S. Researchers Conducted Coronavirus Experiments,” The Defender, Jan. 4, 2022. 57 Ibid. 58 David Franz to James LeDuc, “Re: Arms controllers informal discussion,” Jun. 2, 2021 (Obtained through a Texas Public Information Act request to the University of Texas Medical Branch by US Right to Know). 59 Denise Grady, “Deadly Germ Research Is Shut Down at Army Lab over Safety Concerns,” New York Times, Aug. 5, 2019. 60 Ibid. Page 2 of 3«123»